Wei‐Ting Hwang
Impact in
Papers in
- Oncology 82
- CAR-T cell therapy research 33
- Cancer Immunotherapy and Biomarkers 13
-
- Breast Cancer Treatment Studies 26
- Co-authors
- Lawrence J. Solin (28 shared papers)Linda D. Scott (5 shared papers)Ann E. Rogers (5 shared papers)Carl H. June (17 shared papers)Eleanor E R Harris (19 shared papers)Bruce L. Levine (13 shared papers)Curtiland Deville (22 shared papers)David F. Dinges (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (29 papers)Blood (13 papers)Cancer (12 papers)Clinical Cancer Research (8 papers)Nature Medicine (6 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Wei‐Ting Hwang
263 papers receiving 20.5k citations
Wei‐Ting Hwang's Hit Papers
Peers
Comparison fields: 5 of 169
- Oncology 7.9k
- Virology 650
- Cancer Research 1.5k
- Genetics 845
- Research and Theory 327
Countries citing papers authored by Wei‐Ting Hwang
This map shows the geographic impact of Wei‐Ting Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Hwang more than expected).
Fields of papers citing papers by Wei‐Ting Hwang
This network shows the impact of papers produced by Wei‐Ting Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Hwang. The network helps show where Wei‐Ting Hwang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ting Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia Hit paper breakdown → | 2015 | 1487 |
| 2 | Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia Hit paper breakdown → | 2018 | 1435 |
| 3 | CRISPR-engineered T cells in patients with refractory cancer Hit paper breakdown → | 2020 | 1181 |
| 4 | Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV Hit paper breakdown → | 2014 | 1111 |
| 5 | The Working Hours Of Hospital Staff Nurses And Patient Safety Hit paper breakdown → | 2004 | 741 |
| 6 | B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma Hit paper breakdown → | 2019 | 648 |
| 7 | Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells Hit paper breakdown → | 2012 | 557 |
| 8 | Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis Hit paper breakdown → | 2011 | 551 |
| 9 | 2015 | 494 | |
| 10 | PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial Hit paper breakdown → | 2022 | 434 |
| 11 | Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer Hit paper breakdown → | 2018 | 407 |
| 12 | 2007 | 334 | |
| 13 | 2006 | 330 | |
| 14 | 2006 | 319 | |
| 15 | 2013 | 291 | |
| 16 | 2004 | 282 | |
| 17 | 2008 | 279 | |
| 18 | Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results Hit paper breakdown → | 2024 | 267 |
| 19 | 2005 | 245 | |
| 20 | 2016 | 237 |
About Wei‐Ting Hwang
Wei‐Ting Hwang is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Genetics, having authored 272 papers that have together received 21.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (33 papers), Breast Cancer Treatment Studies (26 papers), Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Childhood Cancer Survivors' Quality of Life (12 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Diversity and Career in Medicine (11 papers) and Bladder and Urothelial Cancer Treatments (11 papers). The work is most often cited by research in Oncology (7.9k citations), Virology (650 citations), Cancer Research (1.5k citations), Genetics (845 citations) and Research and Theory (327 citations). Wei‐Ting Hwang has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Lawrence J. Solin, Linda D. Scott, Ann E. Rogers, Carl H. June, Eleanor E R Harris, Bruce L. Levine, Curtiland Deville, David F. Dinges, Anne E. Kazak and Jan Joseph Melenhorst. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Blood, Cancer, Clinical Cancer Research and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.